Recent evidence from a placebo-controlled randomised clinical trial (COVID-OUT trial: https://doi.org/10.1016/S1473-3099(23)00299-2) has shown that …| www.opensafely.org
We estimate that more than 5.8 million people in the UK are living with diabetes, which is an all-time high. Our data shows that almost 4.6 million people in the UK live with diabetes diagnoses. Additionally, nearly 1.3 million people could be living with type 2 diabetes who are yet to be diagnosed.| Diabetes UK
We are a group of interdisciplinary scientists consisting of medical statisticians, epidemiologists and health data scientists.| www.bristol.ac.uk
Iain Dillingham – Senior Developer at the Bennett Institute for Applied Data Science.| www.bennett.ox.ac.uk
Objectives UK Biobank is a UK-wide cohort of 502,655 people aged 40–69, recruited from National Health Service registrants between 2006–10, with healthcare data linkage. Type 2 diabetes is a key exposure and outcome. We developed algorithms to define prevalent and incident diabetes for UK Biobank. The algorithms will be implemented by UK Biobank and their results made available to researchers on request. Methods We used UK Biobank self-reported medical history and medication to assign pre...| journals.plos.org
Background COVID-19 pandemic restrictions may have influenced behaviours related to weight. Aim To describe patterns of weight change among adults living in England with type 2 diabetes (T2D) and/or hypertension during the pandemic. Design and setting An observational cohort study using the routinely collected health data of approximately 40% of adults living in England, accessed through the OpenSAFELY service inside TPP. Method Clinical and sociodemographic characteristics associated with ra...| British Journal of General Practice